Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The DNA end-joining protein
Ku70
is one of several proteins that inhibit apoptosis by sequestering the proapoptotic factor Bax from the mitochondria. However, the molecular mechanism underlying
Ku70
-dependent inhibition of Bax is not fully understood. Here, we show that the absence of
Ku70
results in the accumulation of ubiquitylated Bax. Under normal growth conditions, Bax ubiquitylation promotes its degradation. Upon induction of apoptosis in wild-type cells, a significant reduction in the levels of ubiquitylated Bax was observed, whereas in
Ku70
(-/-) cells, the ubiquitylated Bax was robustly accumulated. Addition of recombinant
Ku70
into a protein extract of
Ku70
(-/-) cells resulted in a decrease in the levels of ubiquitylated Bax, even in the presence of proteasome inhibitors. Moreover, an in vitro deubiquitylation assay demonstrated that recombinant
Ku70
hydrolyzed
polyubiquitin
chains into monoubiquitin units. Thus,
Ku70
regulates apoptosis by sequestering Bax from the mitochondria and mediating Bax deubiquitylation. These results shed light on the role of proteasome inhibitors as tumor suppressors.
...
PMID:Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation. 1836 50
Mcl-1 is a unique antiapoptotic Bcl2 family member with a short half-life due to its rapid turnover through ubiquitination. We discovered that
Ku70
, a DNA double-strand break repair protein, functions as a deubiquitinase to stabilize Mcl-1.
Ku70
knockout in mouse embryonic fibroblast (MEF) cells or depletion from human lung cancer H1299 cells leads to the accumulation of polyubiquitinated Mcl-1 and a reduction in its half-life and protein expression. Conversely, expression of exogenous
Ku70
in
Ku70
(-/-) MEF cells restores Mcl-1 expression. Subcellular fractionation indicates that
Ku70
extensively colocalizes with Mcl-1 in mitochondria, endoplasmic reticulum and nucleus in H1299 cells.
Ku70
directly interacts with Mcl-1 via its C terminus (that is, aa 536-609), which is required and sufficient for deubiquitination and stabilization of Mcl-1, leading to suppression of apoptosis. Purified
Ku70
protein directly deubiquitinates Mcl-1 by removing K48-linked
polyubiquitin
chains.
Ku70
knockdown not only promotes Mcl-1 turnover but also enhances antitumor efficacy of the BH3-mimetic ABT-737 in human lung cancer xenografts. These findings identify
Ku70
as a novel Mcl-1 deubiquitinase that could be a potential target for cancer therapy by manipulating Mcl-1 deubiquitination.
...
PMID:Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis. 2476 31